Surveillance of antimicrobial resistance in Europe 2018
The results presented in this report are based on antimicrobial resistance (AMR) data from invasive isolates reported to the European Antimicrobial Resistance Surveillance Network (EARS-Net) by 30 European Union (EU) and European Economic Area (EEA) countries in 2019 (data referring to 2018), and on trend analyses of data reported by the participating countries for the period 2015 to 2018.
Antimicrobial consumption - Annual Epidemiological Report for 2018
In 2018, the average total consumption (community and hospital sector combined) of antibacterials for systemic use (ATC group J01) in the EU/EEA was 20.1 DDD per 1 000 inhabitants per day (country range: 9.7–34.0). During the period 2009–2018, no statistically significant change was observed for the EU/EEA overall.
Smallpox - Annual Epidemiological Report for 2018
Smallpox was declared eradicated in 1980. There were no reports of confirmed or possible smallpox in the EU/EEA or other countries for 2018.
Tularaemia Annual Epidemiological Report for 2018
For 2018, 18 countries in the EU/EEA reported 441 cases of tularaemia, 358 (81%) of which were confirmed. The EU/EEA notification rate for 2018 was 0.07 cases per 100 000 population. The male-to-female ratio was 1.7:1. As in previous years, the notification rate among males was higher in most age groups except for the age groups between 5 and 24 years. Notification rates increased with age and peaked at 45–64 years.
Monthly measles and rubella monitoring report, November 2019
The monitoring report is based on measles and rubella data from The European Surveillance System (TESSy) for 1 October 2018 to 30 September 2019. Twenty-nine countries reported measles data for September 2019, of which 280 cases were reported by 17 countries; 12 countries reported no cases. Overall, case numbers continued to decrease compared with the previous two months. Romania and France had the highest case counts with 112 and 56 cases, respectively. Notable decreases were reported in France, Italy, the United Kingdom and Lithuania.
Influenza virus characterisation, October 2019
This is the first report for the 2019–20 influenza season. As of week 44/2019, 1 138 influenza detections across the WHO European Region had been reported; 80% type A viruses, with A(H3N2) prevailing over A(H1N1)pdm09, and 20% type B viruses, with 26 of 27 (96%) ascribed to a lineage being B/Victoria.
Congenital toxoplasmosis - Annual Epidemiological Report for 2017
In 2017, 194 confirmed cases of congenital toxoplasmosis were reported in the EU/EEA, with France accounting for 79% of all confirmed cases due to active screening of pregnant women. The overall notification rate was 5.3 cases per 100 000 live births. No seasonal pattern was observed for the disease.
Yersiniosis - Annual Epidemiological Report for 2018
For 2018, 29 countries reported 7 204 confirmed yersiniosis cases in the EU/EEA. The overall notification rate was 1.7 per 100 000 population and remained stable from 2014 to 2018. The highest rates were reported by Finland, Belgium and the Czech Republic. The highest rate was detected in 0-4 year-old children; 7.9 per 100 000 population for males and 6.8 per 100 000 population for females.
Influenza virus characterisation, September 2019
This is the tenth and final report for the 2018–19 influenza season. As of week 39/2019, 205 947 influenza detections across the WHO European Region had been reported; 99% type A viruses, with A(H1N1)pdm09 prevailing over A(H3N2), and 1.2% type B viruses, with 86 of 165 (52%) ascribed to a lineage being B/Yamagata.